fbpx
Donate Toggle Menu

Opdivo plus Cabometyx improved overall RCC survival

In the phase III CheckMate-9ER trial, nivolumab (Opdivo) plus cabozantinib (Cabometyx) combined improved overall survival (OS) and progression-free survival (PFS) compared with sunitinib (Sutent) in patients with advanced renal cell carcinoma (RCC) who had not…

Kidney cancer positives that might come from this pandemic

During these challenging days, I’ve been searching for any possible positives that might come out of this healthcare crisis we’re in together. Here are a few: Possibly we will learn that less immunotherapy (fewer doses)…

How kidney cancer affects the risks of coronavirus

Many kidney cancer patients and caregivers are concerned about the risk of getting and/or becoming very ill if infected by the novel coronavirus COVID-19. In discussions on Facebook, online support networks, and other social media…

Learn about the 2019 KCA grant recipients

As the award cycle for the 2020 Young Investigator Awards (YIAs) and Advanced Discovery Awards (ADAs) opens, we’re reflecting on the 2019 grant recipients. These innovative researchers are helping to advance our understanding of kidney cancer and…

Wrapping up Kidney Cancer Awareness Month

Kidney Cancer Awareness Month has come to a close. We are ending the month in a very different place than we started and amid the spread of the novel coronavirus COVID-19, how to stay safe…

A message from the KCA’s CEO and President about COVID-19

Friends,  Amid the spread of COVID-19 and the justifiable anxiety around the world, we see society is called upon to accept extraordinary burdens when faced with the fragile nature of human life. But the fragility…

Kidney cancer changed how Tracie saw her world

As a wedding photographer, Tracie Taylor observed unique, intimate moments and captured them through her lens. But a kidney cancer diagnosis about four years ago changed that for her. “For a photographer, vision is a…